PF-Atlas › Clinical Trials › NCT00638365
Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa
KB001 · Phase 1
Registry ID
NCT00638365
Phase
Phase 1
Status
Completed
Drug / intervention
KB001
Sponsor
Humanigen, Inc.
Start
2008-03
About this trial
KB001 is evaluated in NCT00638365, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Humanigen, Inc.. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00638365 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.